openPR Logo
Press release

Branded Generics Market Analysis 2018 With Teva Pharmaceuticals, Novartis, Mylan, Abbott, Actavis (now Allergan), Sun Pharmaceutical Sdn Bhd and More

08-03-2018 04:38 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Branded Generics

Branded Generics

Forecasting Global Branded Generics Market Analysis By Formulation Type (Oral, Parental, Topical), By Therapeutic Application (Oncology, Cardiovascular, Diabetes, Neurology, Gastrointestinal, Dermatology, Analgesics and Anti-inflammatory), By Category (Simple Generics, Super Generics, Biosimilars), By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Others) By End User (Hospital, Clinic, Ambulatory Center) and By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) With Industry Trends and Forecast to 2024.

The Branded Generics Market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. This accounted to USD 190.3 billion in 2016 growing at a CAGR of 7.5% during the forecast period of 2017 to 2024.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-branded-generics-market

The branded generics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of branded generics market for global, Europe, North America, Asia Pacific and South America.

Branded Generics Market Major Market Competitors:

Some of the major players operating in branded generics market are
Teva Pharmaceutical Industries Ltd., Novartis International AG., Mylan N.V., Abbott Healthcare Pvt Ltd., Actavis pharmaceuticals, Sun Pharmaceutical Industries Limited, Allergan, STADA Arzneimittel, Lupin Pharmaceuticals, Aspen Pharmacare Holding, Dr. Reddy’s, Aurobindo, Cipla, Novartis AG, Pfizer , Eva Pharmaceutical Industries , Abbott Laboratories, Valeant Pharmaceuticals International among others

Speak to Research Analyst for Further Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-branded-generics-market

Branded Generics Market Segmentation

By formulation type the market for branded generics market is segmented into oral, parental, topical. By therapeutic application the branded generics market is segmented into oncology, cardiovascular, diabetes, neurology, gastrointestinal, dermatology, analgesics and anti-inflammatory.

On the basis of drug class the market is segmented into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics, others. By category the market is segmented into simple generics, super generics, biosimilars.

On the basis of end-users the branded generics market is segmented into hospital, clinic, and ambulatory center.

On the basis of geography, branded generics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-branded-generics-market

About Us
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Branded Generics Market Analysis 2018 With Teva Pharmaceuticals, Novartis, Mylan, Abbott, Actavis (now Allergan), Sun Pharmaceutical Sdn Bhd and More here

News-ID: 1162206 • Views:

More Releases from Data Bridge Market Research

X-Ray Inspection Systems Market Size, Share, Trends, Demand, Growth, Challenges …
X Ray Inspection System Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Analysis and estimation of important industry trends, market size, and market share are mentioned in the market report. The usefulness of SWOT analysis and Porter's Five Forces analysis in generating market research report makes it preferable by
Hypercalcemia Treatment Market Size, Share, Trends, Key Drivers, Growth Opportun …
Hypercalcemia Treatment Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Analysis and estimation of important industry trends, market size, and market share are mentioned in the market report. The usefulness of SWOT analysis and Porter's Five Forces analysis in generating market research report makes it preferable by the businesses
Nerve Repair Biomaterials Market Size, Share, Trends, Demand, Industry Growth an …
Recent study report released by Data Bridge Market research titled Global Nerve Repair Biomaterials Market (covering USA, Europe, China, Japan, India, South East Asia and etc) that highlighting opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. A top notch Nerve Repair Biomaterials market analysis report contains the recent industry status alongside advanced trends that can impact the actual growth rate of the market. The report gives details of
Single Tooth Implants and Dental Bridges Market Size, Share, Demand, Rising Tren …
Data Bridge Market research has recently issued comprehensive industry research on Global Single Tooth Implants And Dental Bridges Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report. Besides, Single Tooth Implants And Dental Bridges market report studies market growth opportunities and restraining factors. The geographical division of this market analysis report offers data that gives an idea of the revenue of the companies and sales

All 5 Releases


More Releases for Generics

Japan Generics Drug Market Outlook 2020 Report
“Japan Generics Drug Market Outlook 2020” Report Highlights: * Introduction to Japanese Generic Drug Market * Attractiveness of Japanese Generic Market * Super Generics in Japan * Japan Healthcare System & Generic Drugs * Different Parameters for Generic & Branded Drugs * Comparison of Generic Drugs in US & Japan * Japan Generics Drug Market Analysis * Japan Generics Drug Market Future Prospects Download Report Sample Weblink: https://www.kuickresearch.com/report-Japan-Generics-Drug-Market-Outlook-2020.php For Report Sample Contact: neeraj@kuickresearch.com Table of Contents 1. Introduction to
Sterile Injectables: Opportunities Galore for Generics Manufacturers
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide. According to Piramal, the development and manufacturing of sterile injectables is highly complex and capital intensive. The operative cost for injectable is high as almost all injectables in present pharma market are toxic
Animal Pharm: Generics
ReportsWorldwide has announced the addition of a new report title Animal Pharm: Generics to its growing collection of premium market research reports. In 2015, the global animal health market was worth an estimated $30bn. This new thoroughly revised and updated Animal Pharm Generics report focuses primarily on the European and North American markets that comprise around 67% of the global market for animal health products. Also fully reviewed are the EU
Japan Generics Drug Market Japan Generics Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Japan Generic Drug Market 1.1 Reasons for Growth of Japan Generic Market 1.2 Some Misconceptions Related to Generic Drugs in Japan 2. Attractiveness of Japan Generic Market 2.1 Overview of Japan Pharmaceutical Market 2.2 Features of Japan Generic Drugs Market 2.3 Generic Drug Firms in Japan 2.4 Generic Drugs Import in Japan
Japan Generics Drug Market Outlook 2020
Japan is a small island nation located in East Asia and it is known for its economic prosperity. It sports one of the largest pharmaceutical markets like US and Europe due to which immense commercialization opportunities are present. Unique demographic structure and presence of advanced technology is the main reason for the growth of Japanese pharmaceutical industry. They have one of the most advanced research and development facilities across the
US Cancer Generics Market Outlook 2022
“US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market in US. The report analyzes various clinical and non-clinical parameters responsible for the growth on cancer generics drugs in recent years. The introduction of generics has resulted in saving of billions of dollars for various stake holders involved US